Showing 1691-1700 of 3039 results for "".
MATV News: Galderma and Zeltiq Collaborate; Highlights from Cosmetic Surgery Forum
https://modernaesthetics.com/series/matv-news/matv-news-galderma-and-zeltiq-collaborate-highlights-from-cosmetic-surgery-forum/33388/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, Galderma and Zeltiq collaborate, Cosmetic Surgery Forum wraps seventh successful year, Modernizing Medicine introduces modmed PM, and Modern Aesthetics® magazine editorial board discuss what was hot in 2015 and share 2016MATV News: Zeltiq Introduces CoolMini; Juvederm Ultra XC Approved for Lips
https://modernaesthetics.com/series/matv-news/matv-news-zeltiq-introduces-coolmini-juv-derm-ultra-xc-approved-for-lips/33395/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, Zeltiq introduces CoolMini for submental fat, Juvéderm is approved for lips, and Syneron launches Picoway Resolve. Also in this edition, we discuss HARMONY study results and topical toxins.MATV News: Long-Term Efficacy Results for Bellafill; Clear + Brilliant Pélo Cleared for Hair Removal
https://modernaesthetics.com/series/matv-news/matv-news-long-term-efficacy-results-for-bellafill-clear-brilliant-pelo-cleared-for-hair-removal/33416/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, we review the five-year efficacy results for Suneva's Bellafill and why needle size matters for neurotoxin injections. Also in this edition, FDA approves Solta's Clear + Brilliant Pélo for hair removal, AAFPRS Annual MeetMATV News: FDA Approves Cellfina to Treat Cellulite; miraDry to Launch miraSmooth
https://modernaesthetics.com/series/matv-news/matv-news-fda-approves-cellfina-to-treat-cellulite-miradry-to-launch-mirasmooth/33419/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, we review the FDA's clearance of Cellfina to treat cellulite with no loss of benefit for up to two-years as well as the new indication for miraDry for hair removal and the launch of miraSmooth. Also in this edition, FDA aComing & Going: November/December 2022
https://modernaesthetics.com/ma-issues-index/2022-nov-dec/coming-going-novemberdecember-2022/35236/Combining Thread Lifting and Filler Injections
https://modernaesthetics.com/topics/injectables/combining-thread-lifting-and-filler-injections/35411/Coming & Going: February 2023
https://modernaesthetics.com/topics/practice-development/coming-going-february-2023/35254/Obagi Clinical Environmental Defense Serum
https://modernaesthetics.com/topics/minimally-invasive/obagi-clinical-environmental-defense-serum/35180/Consumers Believe in Price Transparency. So Should You!
https://modernaesthetics.com/ma-issues-index/2016-sept-oct/consumers-believe-in-price-transparency-so-should-you/34351/While some core specialists worry about losing patients to less expensive competitors, one expert sees price transparency as a benefit.Non-prescription Skincare for Skin of Color: Tips on Product Recommendation
https://modernaesthetics.com/topics/skincare/non-prescription-skincare-for-skin-of-color-tips-on-product-recommendation/33953/Patients with skin of color can select from a growing array of skincare products to meet their needs.